Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Colloid and Interface Science|October 15, 2014
Neuropeptide Y and its C-terminal fragments acting on Y2 receptor: Raman and SERS spectroscopy studiesHelena Domin, Ewa Pięta, Natalia Piergies, et al.
Neurochemistry International|March 23, 2011
Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in ratsElżbieta Lorenc-Koci, Tomasz Lenda, Lucyna Antkiewicz-Michaluk, et al.
Neurochemistry International|July 7, 2009
Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitroMałgorzata Kajta, Dorota Makarewicz, Elzbieta Ziemińska, et al.
ACS Chemical Neuroscience|July 4, 2019
Characterization of the Brain Penetrant Neuropeptide Y Y2 Receptor Antagonist SF-11Helena Domin, Natalia Piergies, Ewa Pięta, et al.
Frontiers in Pharmacology|May 4, 2026
Impact of chronic SSRI administration on memory parameters, lipid components and membrane properties in C57Bl/6J miceMichał Szuwarzyński, Anna Kostecka, Helena Domin, et al.
Neurotoxicity Research|May 21, 2014
Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's diseaseJolanta Konieczny, Danuta Jantas, Tomasz Lenda, et al.
Behavioural Brain Research|October 23, 2023
The antidepressant-like and glioprotective effects of the Y2 receptor antagonist SF-11 in the astroglial degeneration model of depression in rats: Involvement of glutamatergic inhibitionHelena Domin, Jolanta Konieczny, Paulina Cieślik, et al.
Neuropharmacology|December 1, 2019
Simultaneous activation of mGlu2 and muscarinic receptors reverses MK-801-induced cognitive decline in rodentsPaulina Cieślik, Helena Domin, Agnieszka Chocyk, et al.
Pageof 4